Correction: Ultrasound-derived gestational sac triple product as a predictor of early medical abortion failure with mifepristone-misoprostol regimens: a retrospective cohort study - Summary - MDSpire

Correction: Ultrasound-derived gestational sac triple product as a predictor of early medical abortion failure with mifepristone-misoprostol regimens: a retrospective cohort study

  • By

  • Rui-Hong Xue

  • Juan Li

  • Yun-Xia Li

  • Zhao-Ying Gu

  • Dan Tang

  • Jing Yang

  • Yan-Yan Fu

  • Xin-Liang Chen

  • Ping Liu

  • July 13, 2026

Share

Objective:

To correct the ethics statement in the original article regarding the approval of the study.

Approach:
  • Correction of Ethics Statement: The ethics statement was updated to reflect the correct approval details from the Human Research Ethics Committee.
Key Findings:
  • The original ethics statement was incorrectly cited.
  • The correct approval date is November 24, 2025.
Interpretation:

The need for informed consent was waived by the Committee as per the corrected statement.

Conclusion:

The article has been updated to reflect the accurate ethics approval information.

Sources:

Original Source(s)

Related Content